Innovate UK is a government-backed agency supporting business-led innovation across the United Kingdom.
The pre-seed round was led by Science Angel Syndicate and Fink Family Office to develop cold chain-free vaccine technology.
"Our goal are to make the transportation of vaccines and other life-saving biological materials more efficient and cost-effective while also reducing the carbon footprint of this critical supply chain. We are thrilled to have the support of our investors as we work towards this mission."
The medtech startup will use the fresh capital to bring its pharmacist digitisation software to market.
"Using just an NHS number, we can create personalised, contextualised insights that will help people stay well. We’re so grateful to receive this additional Innovate UK backing so we can scale this application of our software and move a step closer towards creating a single source of truth for medicines data in the UK."
Octopus Ventures led the seed financing round to help the Sheffield spin-out commercialise its infrared sensors.
"We are delighted to be leading this investment round for Phlux Technology, as this innovative breakthrough is critical to the future direction of transport, communication and emission monitoring systems,"
The seed round was led by AlbionVC to fuel international distribution and technological expansion.
"The idea for OutThink was born out of frustration that existing solutions on the market were failing, yet it also came from a passionate belief that if we engaged people beyond traditional security awareness training into human risk management, we could make them the organisation's strongest defence mechanism. We are delighted to welcome AlbionVC, TriplePoint and Gapminder to our team as we create a new category within the cybersecurity solutions market."
The pre-seed round was led by QUBIS Innovation Fund and will support clinical trial preparations and engineering hires.
"We are delighted to have led this investment round into Transdermal Diagnostics. The transdermal approach for glucose monitoring that Transdermal Diagnostics is developing will have a disruptive impact on the diabetes market, we are additionally excited by the company’ potential to expand into the wellness and sports nutrition industries. This funding round alongside the Innovate UK funding will help support them in this journey."
